Form 4: Outset Medical Executive Granted 5,617 RSUs

Outset Medical's EVP of R&D, Operations and Service, Marc Nash, was granted 5,617 restricted stock units.

Summary

• Marc Nash, Executive Vice President of R&D, Operations and Service at Outset Medical, Inc. (OM), was granted 5,617 restricted stock units (RSUs).
• The transaction date for this grant was August 25, 2025.
• Each RSU represents a contingent right to receive one share of common stock.
• The RSUs will vest 33.33% on August 15, 2026, with the remaining 66.67% vesting in equal quarterly installments over the subsequent two years, specifically on February 15th, May 15th, August 15th, and November 15th.
• Vesting is contingent upon Mr. Nash's continuous service through the applicable vesting dates.
• Following this transaction, Marc Nash beneficially owns 48,515 shares of common stock directly.

Sentiment

Score: 6

Explanation: The filing reports a routine executive compensation event, which is generally a neutral to slightly positive signal for executive retention and alignment with shareholder interests, but does not indicate significant new operational or financial developments.

Positives

• The grant of restricted stock units aligns executive interests with shareholder value, incentivizing long-term performance and retention.
• This is a standard component of executive compensation, indicating ongoing commitment to key management personnel.

Industry Context

The grant of restricted stock units to an executive is a common practice in the medical device and technology sectors, used to attract, retain, and motivate key talent by linking their compensation to the company's long-term stock performance.

Stakeholder Impact

• Shareholders: The RSU grant aligns executive incentives with long-term shareholder value creation.
• Employees: Reflects standard executive compensation practices, potentially signaling stability in leadership.

Next Steps

• The granted RSUs will vest according to the specified schedule, contingent on continuous service.

Key Dates

Recommendation

This Form 4 reports a routine grant of restricted stock units to an executive, which is a standard component of compensation and does not provide new information to alter an investment recommendation. It is a non-event in terms of immediate stock price impact or fundamental company outlook.

Keywords

Outset Medical, OM, Form 4, Restricted Stock Units, RSU, Executive Compensation, Insider Transaction, Stock Grant